You have 9 free searches left this month | for more free features.

pituitary tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

DNA Methylation on the Invasiveness of Pituitary Tumors.

Recruiting
  • Pituitary Tumors
  • no interventions between two groups
  • Hanzhou, Zhejiang, China
    2ndAffiliated Hospital, School of Medicine
Dec 1, 2022

Pituitary Tumors and Related Hypothalmic Disorders

Recruiting
  • Panhypopituitarism
  • +3 more
  • MRI
  • Tissue specimen collection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Imaging Features in Invasiveness and Prognosis of Pituitary

Recruiting
  • Pituitary Adenoma
  • Neuroendocrine Tumors
  • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Aug 24, 2023

Pituitary Tumor, Pain Trial in Phoenix (IV Caldolor, IV Placebo)

Completed
  • Pituitary Tumor
  • Pain
  • IV Caldolor
  • IV Placebo
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Oct 5, 2021

Pituitary Tumor, ACTH-producing Pituitary Tumour Trial in New York (Pasireotide LAR)

Terminated
  • Pituitary Tumor
  • ACTH-producing Pituitary Tumour
  • Pasireotide LAR
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University
Mar 31, 2021

Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial

Active, not recruiting
  • Pleuropulmonary Blastoma
  • +9 more
    • Washington, District of Columbia
      Children's National Medical Center
    Mar 9, 2022

    68-Ga DOTATATE PET/MRI in Diagnosis and Management of

    Recruiting
    • CNS Tumors
    • +6 more
    • Ga68-DOTATATE-PET/MRI
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022

    Cystic Tumors of the Sellar/Parasellar Region Trial in Halifax (90yttrium colloid)

    Recruiting
    • Cystic Tumors of the Sellar/Parasellar Region
    • 90yttrium colloid
    • Halifax, Nova Scotia, Canada
      Halifax Infirmary
    Jan 17, 2023

    Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

    Not yet recruiting
    • Cognition
    • +5 more
    • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
    • +3 more
    • Gent, Belgium
    • +2 more
    Feb 3, 2023

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Brain Cancer, Pituitary Adenoma Trial in New York (89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging, Blood and Urine samples)

    Recruiting
    • Brain Cancer
    • Pituitary Adenoma
    • 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging
    • Blood and Urine samples
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 11, 2022

    Brain and CNS Tumors Trial in Los Angeles (rosiglitazone maleate)

    Terminated
    • Brain and Central Nervous System Tumors
    • rosiglitazone maleate
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Aug 5, 2020

    International PPB/DICER1 Registry

    Recruiting
    • Pleuropulmonary Blastoma
    • +14 more
      • Minneapolis, Minnesota
        Children's Minnesota
      Aug 16, 2022

      Brain and CNS Tumors Trial (drug, genetic, other)

      Withdrawn
      • Brain and Central Nervous System Tumors
      • (no location specified)
      Jul 29, 2020

      Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

      Active, not recruiting
      • Cushing's Disease
      • +8 more
      • La Jolla, California
      • +93 more
      May 19, 2022

      Pituitary Adenomas, Prolactinomas Trial in Los Angeles, Baltimore, Boston (Lapatinib)

      Completed
      • Pituitary Adenomas
      • Prolactinomas
      • Los Angeles, California
      • +2 more
      Jan 13, 2020

      Somatostatin Receptors and GH Receptor Expression on Bone of

      Completed
      • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
      • Trans-sphenoidal surgery
      • Roma, Italy
        Fondazione Policlinnico Gemelli IRCCS
      Apr 6, 2023

      Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)

      Not yet recruiting
      • Cushing's Disease
      • Pituitary Adenoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Pituitary Tumor Trial run by the NINDS (ESC)

      Completed
      • Pituitary Neoplasm
      • ESC
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 25, 2022

      Pituitary Adenoma Trial in Nantong (Excision of pituitary tumor outside pseudocapsule)

      Not yet recruiting
      • Pituitary Adenoma
      • Excision of pituitary tumor outside pseudocapsule
      • Nantong, Jiangsu, China
        Affiliated Hospital of Nantong University
      Jul 19, 2022

      Pituitary Trial in Modena

      Not yet recruiting
      • Pituitary
        • Modena, Italy
          Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
        Oct 26, 2022

        Clinically Nonfunctioning Pituitary Adenomas

        Recruiting
        • Pituitary Adenoma
        • Pituitary Tumor
        • Surgical intervention for CNFA
        • Radiotherapy for CNFA
        • New York, New York
          Columbia University Vagelos College of Physicians & Surgeons
        Oct 24, 2022

        Pituitary Adenoma Trial (sevoflurane, propofol)

        Not yet recruiting
        • Pituitary Adenoma
        • (no location specified)
        Apr 19, 2023

        Pituitary Tumours Trial in Göteborg (Gallium-68 DOTATOC PET)

        Terminated
        • Pituitary Tumours
        • Gallium-68 DOTATOC PET
        • Göteborg, Sweden
          Center of Endocrinology and Metabolism, Sahlgrenska university H
        Mar 15, 2022